Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 20, 2024 - Botanix announced the FDA approval of Sofdra (sofpironium), treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older.
Download PDF
Return to publications
